| 1 | Approval of FY2025 reports and financial statements, Board and committee reports, discharge of liability, and tax compliance matters | Oppose |
| 2 | Ratification of Board and management actions and discharge of liability for FY2025 | Oppose |
| 3 | Approval of FY2025 standalone and consolidated financial statements and the external auditor's report | Oppose |
| 4 | Approve Financial Statements and Allocation of Income | Oppose |
| 5 | Approve the Dividend (MXN 20.80) from distributable retained earnings | For |
| 6 | Cancellation of the unused share buyback reserve and approval of a new MXN 2.5 billion share repurchase programme for the following 12 months | For |
| 7 | Report on the appointment or ratification of four Board members and their alternates by Series BB shareholders | Abstain |
| 8 | Appointment of Board members designated by Series B shareholders or shareholders holding at least 10% of share capital | Abstain |
| 9a | Elect Carlos Cárdenas Guzmán - Non-Executive Director | Oppose |
| 9b | Elect Ángel Losada Moreno - Non-Executive Director | Oppose |
| 9c | Elect Joaquín Vargas Guajardo - Non-Executive Director | Oppose |
| 9d | Elect Juan Diez-Canedo Ruiz - Non-Executive Director | Oppose |
| 9e | Elect Luis Tellez Kuenzler - Non-Executive Director | For |
| 9f | Elect Jeronimo Gerard - Non-Executive Director | For |
| 9g | Elect Alejandra Soto - Executive Director | For |
| 10 | Appointment of the Chair of the Board in accordance with the company's bylaws | Abstain |
| 11 | Ratification of Board remuneration for FY2025 and approval of remuneration for 2026 | Abstain |
| 12 | Appointment of a Board member (designated by Series B shareholders) to the Nomination and Compensation Committee | Abstain |
| 13 | Appointment of the Chair of the Audit and Corporate Practices Committee | Abstain |
| 14 | Report on material transactions (≥ USD 3 million) and related-party dealings, if any | Oppose |
| 15 | Appointment of representatives to formalise resolutions | For |
